S 00141 (see companion bill A 06606) – New York
Introduced: 2019 Status: Inactive / Dead
Penalizes the price gouging of pharmaceuticals; penalty not to exceed one million dollars.
S 00256 – New York
Introduced: 2019 Status: Inactive / Dead
Prohibits selling a drug subject to a shortage for an unconscionably excessive price.
S 00803 (see companion bill A 00237) – New York
Introduced: 2019 Status: Inactive / Dead
Relates to price gouging; defines unconscionably excessive price for the purposes of prohibiting price gouging during abnormal disruption of the market.
S 01642 (see companion bill A 02621) – New York
Introduced: 2019 Status: Inactive / Dead
Relates to price gouging; imposes criminal penalties for price gouging; removes language relating to the declaration of a state of emergency; increases civil penalty; authorizes a district attorney to enforce provisions.
S 01798 (see companion bill A 03829) – New York
Introduced: 2019 Status: Inactive / Dead
Prohibits price gouging by manufacturers of prescription drugs.
S 02893 (see companion bill A 01452) – New York
Introduced: 2019 Status: Inactive / Dead
Creates a private right of action for unlawful price gouging for injunctive relief and recovery of compensatory damages or $1,000, whichever is greater, or both, in addition to right of action granted to attorney general; …
S 03654 (see companion bill A 05946) – New York
Introduced: 2019 Status: Inactive / Dead
Prohibits selling a drug subject to a shortage for an unconscionably excessive price.
S 1590 (see companion bill A 3987) – New Jersey
Introduced: 2018 Status: Inactive / Dead
PROHIBITS EXCESSIVE INCREASES IN PRICES CHARGED FOR ESSENTIAL OFF-PATIENT AND GENERIC PRESCRIPTION DRUGS AND BIOLOGICAL PRODUCTS: manufacturers and wholesale distributors may not engage in price gouging in the sale of an essential off-patent or generic …
S 1667 (see companion bill A 2240) – New Jersey
Introduced: 2022 Status: In Process
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
S 243 – Massachusetts
Introduced: 2021 Status: Inactive / Dead
An Act relative to preventing price gouging during an emergency
S 2544 (see companion bill A 5733) – New York
Introduced: 2017 Status: Inactive / Dead
PRICE GOUGING: PRESCRIPTION DRUGS. If a drug manufacturer of a brand or generic drug, made available in New York, increases the wholesale acquisition cost (WAC) of a drug by a percent equal to or greater …
S 2868 – New York
Introduced: 2021 Status: In Process
Creates a private right of action for unlawful price gouging for injunctive relief and recovery of compensatory damages or $1000, whichever is greater, or both, in addition to right of action granted to attorney general; …
S 4536 – New York
Introduced: 2021 Status: In Process
Prohibits price gouging by manufacturers of prescription drugs. Section one adds a new Public Health Law § 276-a which would require any manufacturer of a brand or generic drug to notify the Commissioner of Health …
S 4565 (see companion bill A 5850) – New York
Introduced: 2021 Status: In Process
Relates to price gouging; defines unconscionably excessive price for the purposes of prohibiting price gouging during abnormal disruption of the market.
S 5262 (see companion bill A 7087) – New York
Introduced: 2017 Status: Inactive / Dead
PRICE GOUGING OF MEDICINE: Party within the chain of distribution of any drug subject to a shortage shall sell or offer to sell any such drug subject to a shortage for an amount which represents …
S 652 (accompanied by study order S 2535) – Massachusetts
Introduced: 2017 Status: Inactive / Dead
AN ACT TO PROMOTE TRANSPARENCY AND PREVENT PRICE GOUGING OF PHARMACEUTICAL DRUG PRICES. Would require the Center for Health Information and Analysis to identify prescription drugs sold within the Commonwealth that are (1) the ten …